Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Accenture
Mallinckrodt
Cerilliant
Federal Trade Commission
Fuji
UBS
McKinsey
Farmers Insurance

Generated: June 20, 2018

DrugPatentWatch Database Preview

ESOMEPRAZOLE STRONTIUM Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Esomeprazole Strontium patents expire, and what generic alternatives are available?

Esomeprazole Strontium is a drug marketed by R2 Pharma Llc and is included in one NDA.

The generic ingredient in ESOMEPRAZOLE STRONTIUM is esomeprazole strontium. There are seventy drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the esomeprazole strontium profile page.
Drug patent expirations by year for ESOMEPRAZOLE STRONTIUM
Pharmacology for ESOMEPRAZOLE STRONTIUM
Synonyms for ESOMEPRAZOLE STRONTIUM
(-)-5-Methoxy-2-((S)-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H- benzimidazole strontium salt tetrahydrate
(-)-Omeprazole
(+)-(5)6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole
(5)6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole
(5)6-methoxy-2-[[(4-methoxy-3,5dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole
(5)6-methoxy-2-[[(4methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole
(5)6-methoxy-2[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole
(5)6-methoxy-2[[(4methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole
(5)6-methoxy-2[[(4methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]1H-benzimidazole
(S)-(-)-Omeprazole
(S)-5-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl)-1H-benzo[d]imidazole
(s)-5-methoxy-2-(4-methoxy-3,5-dimethylpyridin-2-ylmethane-sulfinyl)-1h-benzimidazole
(S)-5-Methoxy-2-[(3,5-dimethyl-4-methoxy-2-pyridyl) methylsulfinyl]1-H-benzimidazole
(S)-5-Methoxy-2-[(3,5-dimethyl-4-methoxy-2-pyridyl)methylsulfinyl]-1H-benzimidazole
(s)-5-methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]-3h-benzimidazole
(s)-5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1h-benzimidazole
(S)-5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole
(S)-5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole
(S)-6-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole
(S)-Esomeprazole
(S)-Omeprazole
1116141-00-4
119141-88-7
161796-78-7
177541-03-6
193469-77-1
1H-Benzimidazole, 5-methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2- pyridinyl)methyl)sulfinyl)-
1H-benzimidazole, 6-methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridinyl) methyl)sulfinyl)-, strontium salt, hydrate (2:1:4)
326602-80-6
5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole
5-methoxy-2-[(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methane]sulfinyl]-1H-1,3-benzodiazole
5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1-methyl-1H-benzimidazole
6-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]-1H-1,3-benzodiazole
6-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole
6-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
934714-36-0
AK-54758
AKOS015900821
AKOS016001455
Alenia
AM84543
ANW-57719
AX8209215
Axagon (TN)
BIDD:GT0020
C5N25H3803
CE0111
CHEBI:50275
CHEMBL1201320
CHEMBL2146140
CTK8B7581
D07917
D0C6DT
D10120
DB00736
DTXSID4044292
Escz
Esofag
esomeprazol
Esomeprazole
Esomeprazole (INN)
Esomeprazole [INN:BAN]
Esomeprazole magnesium dihydrate
Esomeprazole magnesium hydrate
Esomeprazole Sodium
Esomeprazole strontium (USAN)
Esomeprazole strontium [USAN]
Esomeprazole strontium tetrahydrate
Esomeprazole(Mg)
esomeprazolum
Esopral (TN)
FM0F67
FT-0689771
GTPL5488
HE211332
HSDB 8158
I14-16344
Inexium paranova
Inexium paranova (TN)
IZRA 40
Losec, Omesec, Prilosec, Zegerid, Omeprazole
Lucen (TN)
MolPort-023-330-012
N3PA6559FT
Nexiam
Nexiam (TN)
Nexium
Nexium (TN)
nexium control
Olit
Omebeta
Omeprazole (JAN/USP/INN)
Omeprazole S-form
QCR-180
S-Omeprazole strontium hydrate
SC-19391
SCHEMBL19535
Sompraz (TN)
ST24036245
SUBDBMMJDZJVOS-DEOSSOPVSA-N
TC-146464
UNII-C5N25H3803
UNII-KG60484QX9 component SUBDBMMJDZJVOS-DEOSSOPVSA-N
UNII-N3PA6559FT
ZINC4693575
Zoleri (TN)

US Patents and Regulatory Information for ESOMEPRAZOLE STRONTIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
R2 Pharma Llc ESOMEPRAZOLE STRONTIUM esomeprazole strontium CAPSULE, DELAYED RELEASE;ORAL 202342-001 Aug 6, 2013 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
R2 Pharma Llc ESOMEPRAZOLE STRONTIUM esomeprazole strontium CAPSULE, DELAYED RELEASE;ORAL 202342-002 Aug 6, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Healthtrust
US Army
Johnson and Johnson
Fuji
Moodys
Mallinckrodt
Medtronic
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.